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Abstract
Diet is important for the prevention of CVD, and diets high in MUFA might be more cardioprotective than low-fat diets. We hypothesise that
inflammation and endothelial cell function will be improved most favourably by a high-MUFA diet compared with a low-fat diet. This was
tested in a parallel randomised intervention trial on overweight individuals (aged 28·2 (SD 4·6) years) assigned to a diet moderate in the
amount of fat (35–45% of energy; .20% of fat as MUFA; MUFA diet, n 39), a low-fat (20–30% of energy) diet (LF diet, n 43) or a control
diet (35 % of energy as fat, n 24) for 6 months after weight loss. Protein constituted 10–20 % of energy in all diets. Food was provided free
of charge. Fasting blood samples were collected before and after the intervention and analysed for C-reactive protein (CRP), IL-6, inter-
cellular adhesion molecule, von Willebrand factor (vWF) and tissue factor pathway inhibitor. vWF concentrations tended to fall on the
LF diet (4·78 (SD 16·44) %; P¼0·07). Concentrations of IL-6 were reduced by the MUFA (0·37 (SD 0·74) pg/ml; P,0·01) and LF (0·47 (SD
0·69) pg/ml; P,0·001) diets, and CRP was reduced on all diets (MUFA: 0·48 (SD 1·93) mg/l (P,0·01); LF: 1·46 (SD 2·89) mg/l (P,0·001);
control: 1·20 (SD 1·97) mg/l (P,0·01)). No significant differences were observed between changes induced by the different diets. Our
findings suggest that in overweight subjects after weight loss, the MUFA and LF diets have similar long-term effects on inflammation
and endothelial cell function.
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Diet is an important factor in the prevention of CVD as
demonstrated in the Nurses’ Health Study, a large prospective
study on 121 700 initially healthy nurses(1), in which high
intakes of SFA, trans-fatty acids and carbohydrates with a
high glycaemic index (GI) were associated with increased
CVD risk(1,2), and high intakes of MUFA and PUFA were
associated with reduced CVD risk(1).
An alternative dietary pyramid has been introduced in the
USA by Willett(3), one of the Nurses’ Health study investi-
gators. The main difference between Willett’s new pyramid
and the US Department of Agriculture (USDA) 2004 Food
Pyramid(4) is that the new pyramid has no restrictions on fat
as long as it is of vegetable origin, and carbohydrates should
have a high content of whole grains. Such a diet is assumed
to have a more cardioprotective effect than a diet following
the USDA 2004 Food Pyramid. Although the Nurses’ Health
Study is a very large and well-designed study, the study con-
clusions should not alone be used to change the established
dietary recommendations without also having results from
long-term controlled comparisons with existing dietary
recommendations. Because a controlled randomised dietary
study in healthy individuals with CVD as the end point will
be practically infeasible, CVD risk markers can be studied as
an alternative.
Inflammation and endothelial dysfunction are key factors
in CVD as illustrated by the association between plasma
variables and the risk of CVD in prospective studies. Associations
have been observed for C-reactive protein (CRP)(5), IL-6(6),
*Corresponding author: E.-M. Bladbjerg, fax þ45 79182430, email ebladbjerg@health.sdu.dk
Abbreviations: CRP, C-reactive protein; GI, glycaemic index; ICAM, intercellular adhesion molecule; TFPI, tissue factor pathway inhibitor; vWF, von
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intercellular adhesion molecule (ICAM-1)(7), von Willebrand
factor (vWF)(8,9) and tissue factor pathway inhibitor (TFPI)(9).
Intervention studies have reported an effect of specific dietary
components on these CVD risk markers, e.g. effects of specific
fatty acids on CRP and IL-6(10–12), and intervention studies
based on dietary advice have observed long-term effects of
complex dietary changes on CRP(13–15).
The aim of the present study was to compare the long-term
effect on markers of inflammation and endothelial cell func-
tion of three different ad libitum diets in a 6-month strictly
controlled dietary intervention in healthy obese subjects
after weight loss. The diets compared were Willett’s new
Healthy Eating Pyramid (high in MUFA and low in GI), the
Official Nordic Dietary Guidelines (low in fat and medium in
GI) and the average Danish diet (high in SFA and high in
GI). We hypothesise that inflammation and endothelial cell
function will be improved most favourably by the diet high
in MUFA and low in GI.
Experimental methods
Study population
The dietary intervention, Mono Unsaturated Fatty acids in
Obesity (MUFObes), was conducted at the Department of
Human Nutrition, Faculty of Life Sciences, University of
Copenhagen (Frederiksberg, Denmark), and has been
described in detail elsewhere(16,17). Briefly, 131 obese individ-
uals were randomly assigned to one of three diets. The
inclusion criteria were age 18–35 years, BMI 28–36 kg/m2,
body-weight fluctuations of ,3 kg over the previous 2
months and a non-smoking status. Subjects were healthy
and took no regular medicine other than contraceptive pills.
All subjects gave oral and written informed consent, and the
Ethics Committee of the Municipalities of Copenhagen and
Frederiksberg approved the study according to the Declara-
tion of Helsinki. The trial was registered at clinicaltrials.gov
as NCT00274729.
The population characteristics at study entry are described
in Table 1. For various reasons, twenty-five participants
dropped out during the intervention period, leaving
thirty-nine participants in the MUFA group, forty-three
participants in the LF group and twenty-four participants in
the control group(16).
Study design
The study was a parallel intervention trial comparing the effect
of three diets on body weight and cardiovascular risk after
6 months of intervention. The study design is presented in
Fig. 1 and has been described in detail previously(18). After
an initial 8-week low-energy diet, only subjects who lost
.8 % of their body weight were randomised to one of the
experimental diets. After randomisation, the participants com-
pleted a 3-week standardisation period (weight stabilisation
and adaptation to the supermarket model) eating a diet resem-
bling the average Danish diet, corresponding to the control
diet. The 6-month intervention study started in May 2004
and ended in November 2004.
The experimental diets
The 6-month dietary intervention was based on an ad libitum
design in order to mimic free-living conditions and to test the
real appetite regulation of the diets. The three prescribed diets
were as follows: (1) the MUFA diet designed to be moderate in
fat (35–45 % of energy), high in MUFA (.20 % of energy) and
moderate in low-GI carbohydrates (40–50 % of energy), with a
high content of vegetable oils, whole-grain food, nuts and
legumes); (2) the LF diet low in fat (20–30 % of energy) and
high in mixed-GI carbohydrates (55–65 % of energy); (3) the
control diet corresponding to the average Danish diet moder-
ate in fat (30–40 % of energy), high in SFA (.15 % of energy),
moderate in high-GI carbohydrates (45–55 % of energy) and
low in fibre (,3 % of energy). All three diets were moderate
in protein (10–20 % of energy). Foods recommended for the
three dietary groups have previously been described(16). The
actual dietary composition (Table 2) was in accordance with
the prescribed dietary composition, and the biopsy content
of fatty acids (assessment of compliance) was in accordance
with the prescribed diets(16).
Table 1. Population characteristics at study entry*
(Mean values and standard deviations)
High-MUFA diet
(n 54)
Low-fat diet
(n 51)
Control diet
(n 26)
Variables Mean SD Mean SD Mean SD
Age (years) 29·2 4·5 27·3 4·9 27·6 5·1
Sex (n)
Male 22 22 11
Female 32 29 15
Body weight (kg) 95·4 12·8 96·9 13·5 93·9 13·8
Height (m) 1·74 0·1 1·75 0·1 1·73 0·1
BMI (kg/m2) 31·4 2·7 31·6 2·7 31·3 2·5
Waist circumference (cm) 102·9 8·8 104·4 8·9 103·8 8·7
Hip circumference (cm) 115·6 8·1 116·3 7·0 114·4 6·5
* Measurements were made at screening before weight loss. Mean values for the three diets were compared with an ANOVA. Sex was
compared using the x 2 test. No significant differences existed between the groups at study entry.
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Supermarket foods, the computer program
and shopping sessions
To provide the subjects with all necessary foods and to accom-
plish a total recording of the food consumed, a validated
supermarket model(18) was established at the department.
The supermarket foods, the computer program and the
shopping sessions have been described extensively else-
where(16,17,19). Throughout the 6 months of intervention,
the subjects obtained all foods and beverages at the study
supermarket, free of charge, and they were instructed to
consume only these foods.
Blood sampling
Venous blood samples were drawn after lying in a supine
position for 10 min after at least 10 h fasting, and 24 h absten-
tion from alcohol and strenuous physical activity.
Blood samples were collected with minimal stasis using
siliconised vacutainers and 21 gauge needles in citrated tubes
at room temperature for analyses of CRP, IL-6, ICAM, vWF,
TFPI, TAG and total cholesterol.
Tubes were centrifuged at 208C for 20 min at 2000g. Plasma
was pipetted into plastic vials and stored at 2708C.
Blood analyses
Plasma samples were rapidly thawed in a water-bath at 378C
and analysed in one series for each subject. Cholesterol,
HDL-cholesterol and TAG were determined enzymatically
with a COBAS INTEGRA (Roche, Mannheim, Germany). LDL
concentration was calculated as follows: LDL ¼ total
cholesterol 2 HDL 2 (TAG/2·2). Concentrations of CRP (mg/l)
were determined by the Latex method (Roche). Commercial
ELISA were used to measure concentrations of IL-6 (pg/ml)
(R&D Systems, Abingdon, Oxon, UK), ICAM (ng/ml) (R&D
Systems), vWF (%) (LiatestwVWF:Ag; Diagnostica Stago,
Asnie`res, France) and total TFPI (ng/ml) (AsserachromwTotal
TFPI; Diagnostica Stago). ELISA used were highly sensitive,
and no results were below the detection limits. The inter-
assay CV were ,6 % for CRP, ,7 % for IL-6, ,7 % for ICAM,
,3 % for vWF and ,8 % for TFPI.
Statistics
Statistical analyses were done on completers only and
performed using the SPSS program (version 16; SPSS, Inc.,
Chicago, IL, USA). The distribution of the results for TAG,
CRP and IL-6 was skewed, and values were logarithmically
Randomisation
end of LED
Intervention start
0 months
8 weeks LED
Standardisation
period (2–3 weeks)
6 months dietary intervention period
Study start
6 months
Fig. 1. Design of the Mono Unsaturated Fatty acids in Obesity study. LED, low-energy diet.
Table 2. Actual nutrient composition of the experimental diets
(Mean values and 95 % confidence intervals)
High-MUFA diet (n 39) LF diet (n 43) Control diet (n 24)
Mean 95 % CI Mean 95 % CI Mean 95 % CI P‡
Energy intake (MJ/d) 11·5 10·6, 12·4 10·5 9·7, 11·3 10·9 9·6, 12·3 0·27
Total fat (E%) 38·4***††† 37·9, 39·0 23·6*** 23·1, 24·1 32·1 31·4, 32·7 ,0·001
SFA (E%) 7·1***††† 6·9, 7·4 7·9*** 7·6, 8·3 15·1 14·7, 15·5 ,0·001
MUFA (E%) 20·2***††† 19·8, 20·6 8·4*** 8·1, 8·6 10·4 10·0, 10·8 ,0·001
PUFA (E%) 7·8***††† 7·6, 8·1 5·2*** 5·1, 5·4 4·0 3·7, 4·3 ,0·001
Carbohydrates (E%) 43·3***††† 42·7, 43·9 57·6*** 57·0, 58·2 49·8 49·2, 50·5 ,0·001
Fibre (g/MJ) 4·2***††† 4·0, 4·4 4·0*** 3·8, 4·2 2·9 2·6, 3·1 ,0·001
Added sugar (E%) 5·4***††† 4·8, 5·9 7·2*** 6·4, 7·9 9·7 8·7, 10·7 ,0·001
Glycaemic index Low Moderate High
Protein (%) 15·3*† 14·9, 15·6 15·8 15·5, 16·2 15·9 15·4, 16·4 0·04
Alcohol (E%) 2·6 1·9, 3·3 2·6 2·0, 3·3 2·0 1·2, 2·8 0·43
LF, low fat; E%, percentage of energy.
Mean value was significantly different from that for control: *P , 0·05, ***P , 0·001 (pairwise analyses).
Mean value was significantly different from that for LF: †P , 0·05, †††P , 0·001 (pairwise analyses).
‡ Mean values for the three diets were compared with an ANOVA.
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transformed before analysis. Fasting values were compared
between the three diets at the start of the intervention
(0 months) and at the end of the intervention (6 months)
using an ANOVA. When significant between-diet effects
were observed, post hoc analyses were performed for
pairwise analyses and adjusted for multiple comparisons by
the Bonferroni test.
For test for differences within groups, fasting values at 6
months were compared with fasting values at 0 months for
each of the three diets separately using a paired t test. Further-
more, differences between the diet groups in changes from
months 0 to 6 for all variables were analysed by a univariate
ANOVA using dietary group as a fixed factor and baseline
values, changes in BMI (or waist:hip ratio), and changes in
total cholesterol and TAG as covariates in order to adjust for
possible confounders. In the case of significance in the
ANOVA, pairwise analyses were performed.
All results are presented as means or geometric means. A P
value of less than 0·05 was considered statistically significant.
Results
Of the study participants, seven were excluded from the stat-
istical calculations due to concentrations of CRP.10 mg/l
(n 6), indicating an inflammatory condition, or very high con-
centrations of ICAM (1434 ng/ml, n 1), signifying pronounced
endothelial cell dysfunction. These seven participants were
distributed as follows: three participants in the MUFA group;
three participants in the LF group; one participant in the
control group (four participants at 0 months and three partici-
pants at 6 months).
There were no significant differences in baseline values
(month 0) between the three experimental diets except for sig-
nificant difference in BMI between the MUFA diet and the LF
diet (Table 3). This difference persisted after 6 months
(P,0·01) with significant differences also between the
MUFA diet and the control diet (P,0·05). No other significant
differences were observed after 6 months between the three
diets (Table 3).
When the effects of 6 months of intervention were analysed
within each dietary group, all three diets resulted in a signifi-
cant increase in BMI (MUFA, 1·28 (SD 1·45) kg/m2; LF, 0·71 (SD
1·12) kg/m2; control, 0·64 (SD 1·34) kg/m2) and a significant
decrease in CRP (MUFA, 0·48 (SD 1·93) mg/l; LF, 1·46 (SD
2·89) mg/l; control, 1·20 (SD 1·97) mg/l). Concentrations of
IL-6 were reduced on the MUFA diet (0·37 (SD 0·74) pg/ml)
and the LF diet (0·47 (SD 0·69) pg/ml). The LF diet also resulted
in a significant decrease in TAG (0·16 (SD 0·37) mmol/l) and a
tendency to a decrease in vWF (4·78 (SD 16·44) %), P¼0·07).
Concentrations of cholesterol were increased on the control
diet (0·21 (SD 0·50) mmol/l; Table 3). No significant changes
were observed in waist:hip ratio, LDL-cholesterol, ICAM and
TFPI (Table 3).
Changes in vWF concentrations from months 0 to 6 tended
to differ between the diet groups (P¼0·07). This was due to
significantly different vWF changes during 6 months (mo)
between the MUFA diet (DvWF 0! 6 moMUFA ¼ 5·60 (SD
23·8) %) and the LF diet (DvWF 0! 6 moLF ¼ 24·78 (SD
16·4) %) (P¼0·022), with a reduction on the LF diet and an
increase on the MUFA diet. However, this difference was no
longer significant (P¼0·21) after adjustment for covariates
due to a significant effect of baseline values and changes in
TAG. No differences between the diet groups in changes
from months 0 to 6 were observed for the other variables
measured.
Discussion
In the present weight-loss maintenance study, CRP concentra-
tion was significantly lowered irrespective of the experimental
diet, and the concentration of IL-6 was lowered by the MUFA
diet and the LF diet (Table 3). We observed a tendency
to reductions in vWF concentrations on the LF diet (P¼0·07)
and not on the MUFA diet. Changes in vWF concentrations
during 6 months differed significantly between the LF and
MUFA diet groups (P¼0·022), but this difference disappeared
after adjustment for covariates. No other significant
differences were observed between changes induced by the
different diets.
The observed effects on vWF may suggest a less favourable
effect on the endothelium of the MUFA diet compared with
the LF diet, but this cannot be confirmed by others. In one
study, vWF concentrations decreased after 4 weeks on a
high-MUFA diet compared with a low-fat diet(20). Others
found no difference in effects on vWF, when comparing a
MUFA diet with either a PUFA diet(21) or a low-fat diet(22).
The significant between-diet effect (MUFA v. LF) observed in
the present study seems to be due to (non-significant) differ-
ences in vWF baseline values. Also, we cannot exclude that
the significantly higher body weight in the MUFA group may
partly explain the less favourable vWF effect of the MUFA diet.
The two other markers of endothelial function, TFPI and
ICAM, were not affected during 6 months by any of the
three diets. Only a few dietary studies have measured TFPI,
with either a decrease in TFPI concentrations after 4 weeks
on a high-MUFA diet compared with a low-fat diet(20) or an
increase in TFPI after 6 weeks on a diet high in marine n-3
fat v. a diet high in vegetable n-3 fat(23). A cross-sectional
study observed an association between high adherence to a
Mediterranean diet and lower concentrations of ICAM(24).
Concentrations of ICAM are not affected by a-linolenic acid
compared with linoleic acid in dyslipaemic men(11).
The most investigated inflammatory marker in dietary
studies is CRP, which can be affected by various dietary com-
ponents. In cross-sectional studies, low concentrations of CRP
are associated with ingestion of a Mediterranean diet(24–26),
nuts and whole-grain food(27), and low-GI diets(28). In inter-
vention studies based on dietary advice, CRP is lowered by
a Mediterranean diet compared with a prudent diet in subjects
with the metabolic syndrome(13), a low-GI diet v. a high-GI
diet in patients with type 2 diabetes(15), a high-carbohydrate/
low-fat diet compared with a low-carbohydrate/high-fat diet
in overweight people(29) and a low-carbohydrate/high-MUFA
diet compared with a low-carbohydrate/high-protein diet in
overweight people(14). Randomised controlled trials have
demonstrated that concentrations of CRP are lowered by
E.-M. Bladbjerg et al.126
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almond-enriched high-MUFA diets compared with a healthy
diet without nuts(30), and by a-linolenic acid compared with
linoleic acid in dyslipaemic men(11–12). Thus, many studies
have suggested that a high-MUFA diet has a favourable
effect on CRP. In the present study, CRP was lowered by all
three dietary regimens. Most probably, this indicates that
the controlled study in itself had a healthy effect on the
study participants, and that all three experimental diets were
healthier than the habitual diets eaten by the overweight
study participants. Alternatively, the reduction in CRP might
be due to an acute-phase reaction in the beginning of the
study caused by a stress situation (substantial negative
energy balance in the low-energy diet period, getting used
to the experimental design and diets, etc.). However, the
participants completed a 3-week standardisation period
(weight stabilisation on the control diet and adaptation to the
supermarket model) before the start of the study. A decrease
over time can also be caused by a seasonal variation, but
there seems to be no variation in CRP concentrations(31,32).
Whatever the reason for the decrease in CRP during the
study period, the minor increase in body weight cannot coun-
teract this effect, and there was no association between
changes in BMI and changes in CRP (r 0·021, P¼0·85) in the
present study and in another study(33).
Table 3. Fasting concentrations of plasma variables before (0 months) and after (6 months) dietary intervention
with a high-MUFA diet (MUFA; n 36), a low-fat diet (LF; n 40) or a control diet (n 23)
(Mean values and standard deviations)
0 months 6 months
Variables Mean SD Mean SD P‡
BMI (kg/m2)
MUFA 28·42† 2·38 29·70*† 2·8 ,0·001
LF diet 26·97 2·09 27·68 2·36 ,0·001
Control 27·47 1·8 28·11 1·79 ,0·05
WHR
MUFA 0·87 0·07 0·87 0·08 0·53
LF 0·87 0·06 0·87 0·05 0·56
Control 0·88 0·06 0·88 0·08 0·59
TAG (mmol/l)§
MUFA 0·93 1·48 0·82 1·48 0·12
LF 1·05 1·52 0·92 1·48 ,0·05
Control 1·05 1·46 0·96 1·46 0·15
Cholesterol (mmol/l)
MUFA 4·49 0·71 4·42 0·69 0·52
LF 4·52 0·93 4·52 1·04 0·98
Control 4·40 0·65 4·64 0·92 0·059
LDL-cholesterol (mmol/l)
MUFA 2·78 0·62 2·68 0·63 0·2
LF 2·78 0·86 2·79 1·05 0·92
Control 2·76 0·66 2·96 0·98 0·11
ICAM (ng/ml)
MUFA 185·6 31·3 191·1 31·2 0·17
LF 195·7 22·4 195·2 22·4 0·87
Control 200·1 21·7 199·3 23·0 0·81
vWF (%)
MUFA 93·9 29·4 99·3 28·8 0·17
LF 105·2 32·1 100·4 30·6 0·07
Control 111·9 36·7 110·9 33·1 0·75
TFPI (ng/ml)
MUFA 64·8 12·1 66·5 13·6 0·30
LF 63·8 15·6 62·0 14·7 0·25
Control 66·9 14·6 64·8 16·9 0·32
CRP (mg/l)§
MUFA 1·52 2·19 0·85 3·19 ,0·01
LF 2·13 2·76 0·89 3·51 ,0·001
Control 2·35 2·34 1·55 2·53 ,0·01
IL-6 (pg/ml)§
MUFA 1·12 1·67 0·81 1·61 ,0·01
LF 1·26 1·76 0·84 1·8 ,0·001
Control 1·27 1·90 1·10 2·29 0·20
WHR, waist:hip ratio; ICAM, intercellular adhesion molecule; vWF, von Willebrand factor; TFPI, tissue factor pathway inhibitor;
CRP, C-reactive protein.
* Mean value was significantly different from that for control (P , 0·05).
† Mean value was significantly different from that for LF (P , 0·05).
‡ Mean values at 0 and 6 months were compared using a paired t test within the diet groups. Between-diet comparisons at 0 and
6 months were performed using an ANOVA. When significant between-diet effects were observed, pairwise comparisons were
performed using the Bonferroni test.
§ TAG, CRP and IL-6 were logarithmically transformed before analysis (geometric means and standard deviations).
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The dietary effect on CRP can be a direct effect of the exper-
imental diets and/or reinforced by the observed reduction in
IL-6, which can affect the hepatic synthesis of CRP(34). In
cross-sectional studies, low concentrations of IL-6 are associ-
ated with ingestion of a Mediterranean diet(24,25) and nuts
and whole-grain food(27). Randomised controlled trials
demonstrate that concentrations of IL-6 are lowered by high-
MUFA oleic acid compared with tran-fatty acid or stearic
acid in healthy men(10), and a-linolenic acid compared with
linoleic acid in dyslipaemic men may either lower IL-6 con-
centrations(12) or has no effect on IL-6(11). Also, concentrations
of IL-6 are not affected by almond-enriched high-MUFA diets
compared with a healthy diet without nuts(30).
Thus, there seems to be no substantial difference between
the three experimental diets (MUFA, LF and control) on the
long-term effect on inflammation and endothelial cell func-
tion. Results from the same study showed that also several
haemostatic variables (d-dimer, prothrombin fragment 1 þ 2,
factor VII coagulant activity and plasminogen activator inhibi-
tor) were not affected by the three diets except for fibrinogen,
which was significantly lowered by the LF diet and not by the
MUFA diet, and this change over time was significantly differ-
ent between the diet groups(35). In contrast, the MUFA diet had
a more favourable effect on glucose homeostasis than the two
other diets(19).
Important strengths of the present study include the
randomised design, the long-term observation, the number
of subjects and the highly controlled supermarket model
providing complex ad libitum diets for free-living individuals.
It is extremely difficult to standardise dietary studies and to
completely control what people are eating, and only a few
long-term controlled dietary studies exist. The present study
therefore adds important information to our present know-
ledge. The selected risk markers were not among the primary
effect variables in the power calculation (which was based on
changes in body weight)(19), but highly significant differences
were observed for CRP and IL-6, and there was not even a
trend towards differences in ICAM and TFPI. We cannot
exclude that we were unable to detect a true vWF difference
between the MUFA diet and the LF diet due to a type 2
error, or due to the significantly higher body weight in the
MUFA group. A limitation of the study is the minor weight
regain in all three dietary groups, which makes comparison
with isoenergetic dietary studies more difficult. However, the
aim of the study was to compare the long-term effect of
three dietary regimens on inflammation and endothelial cell
function during weight maintenance in relatively young sub-
jects. An older (and more atherosclerotic or insulin resistant)
study population might have caused a greater difference in
risk markers within and between the diets.
In conclusion, the MUFA diet was not superior to the LF
diet with respect to long-term effects on inflammation and
endothelial cell function in overweight subjects after weight
loss. Only the LF diet tended to lower plasma vWF, but this
did not result in significant different vWF changes between
the diets. The MUFA diet and the LF diet had similar favour-
able long-term effects on IL-6, and all three diets lowered
CRP. The reduction in CRP on the average Danish diet also
indicates that following a controlled study in itself has a ben-
eficial effect.
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